Page last updated: 2024-10-27

fenofibrate and Extrasystole, Ventricular

fenofibrate has been researched along with Extrasystole, Ventricular in 1 studies

Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE

Research Excerpts

ExcerptRelevanceReference
"Fenofibrate is a peroxisome proliferator-activated receptor (PPAR)-α activator that lowers triglycerides and influences cytochrome P-450 (CYP-450) epoxygenase-dependent arachidonic acid (AA) metabolism."1.48Protective effect of fenofibrate against ischemia-/reperfusion-induced cardiac arrhythmias in isolated rat hearts. ( Al-Masri, AA; Almotrefi, AA; Bukhari, IA; Mohamed, OY; Sheikh, SA, 2018)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bukhari, IA1
Almotrefi, AA1
Mohamed, OY1
Al-Masri, AA1
Sheikh, SA1

Other Studies

1 other study available for fenofibrate and Extrasystole, Ventricular

ArticleYear
Protective effect of fenofibrate against ischemia-/reperfusion-induced cardiac arrhythmias in isolated rat hearts.
    Fundamental & clinical pharmacology, 2018, Volume: 32, Issue:2

    Topics: Animals; Anti-Arrhythmia Agents; Diltiazem; Disease Models, Animal; Fenofibrate; Heart Rate; Isolate

2018